Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma

GOALS AND BACKGROUND: Clinical staging with endoscopic ultrasound (EUS) and positron emission tomography (PET) is used to identify esophageal adenocarcinoma (EAC) patients with locally advanced disease and therefore, benefit from neoadjuvant therapy. However, EUS is operator dependent and subject to...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Gastroenterol
Autori principali: Thota, Prashanthi N., Alkhayyat, Motasem, Cifuentes, Juan David Gomez, Haider, Mahnur, Bena, James, McMichael, John, Sohal, Davender P, Raja, Siva, Sanaka, Madhusudhan R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2022
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8255331/
https://ncbi.nlm.nih.gov/pubmed/33405434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0000000000001489
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi